DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42(NASDAQ:DHCNI) stock Fundamental Analysis

Fundamental Rating

Overall DHCNI gets a fundamental rating of 2 out of 10. We evaluated DHCNI against 130 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHCNI have multiple concerns. DHCNI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

DHCNI had negative earnings in the past year.

DHCNI had a positive operating cash flow in the past year.

DHCNI had negative earnings in 4 of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: DHCNI reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -7.21%, DHCNI is doing worse than 88.46% of the companies in the same industry.

Looking at the Return On Equity, with a value of -18.90%, DHCNI is doing worse than 85.38% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-7.21%
ROE	-18.9%
ROIC	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 17.31%, DHCNI is doing worse than 93.08% of the companies in the same industry.

In the last couple of years the Gross Margin of DHCNI has declined.

The Profit Margin and Operating Margin are not available for DHCNI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.31%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DHCNI has been increased compared to 1 year ago.

The number of shares outstanding for DHCNI has been increased compared to 5 years ago.

Compared to 1 year ago, DHCNI has a worse debt to assets ratio.

2.2 Solvency

DHCNI has an Altman-Z score of 0.16. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 0.16, DHCNI is not doing good in the industry: 68.46% of the companies in the same industry are doing better.

A Debt/Equity ratio of 1.49 is on the high side and indicates that DHCNI has dependencies on debt financing.

The Debt to Equity ratio of DHCNI (1.49) is worse than 60.77% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.49
Debt/FCF	N/A
Altman-Z	0.16

ROIC/WACCN/A

WACC7.02%

2.3 Liquidity

DHCNI has a Current Ratio of 2.83. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 2.83, DHCNI belongs to the top of the industry, outperforming 86.92% of the companies in the same industry.

A Quick Ratio of 2.83 indicates that DHCNI has no problem at all paying its short term obligations.

DHCNI's Quick ratio of 2.83 is amongst the best of the industry. DHCNI outperforms 86.92% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.83
Quick Ratio	2.83

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for DHCNI have decreased strongly by -14.04% in the last year.

The Revenue has been growing slightly by 6.04% in the past year.

The Revenue has been growing slightly by 7.53% on average over the past years.

EPS 1Y (TTM)-14.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%16.28%

Revenue 1Y (TTM)6.04%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%5%

3.2 Future

The Earnings Per Share is expected to grow by 12.65% on average over the next years. This is quite good.

DHCNI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.48% yearly.

EPS Next Y11.5%

EPS Next 2Y12.65%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year4.73%

Revenue Next 2Y5.48%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHCNI. In the last year negative earnings were reported.

Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DHCNI indicates a rather expensive valuation: DHCNI more expensive than 90.00% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	25.69

4.3 Compensation for Growth

DHCNI's earnings are expected to grow with 12.65% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y12.65%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

DHCNI has a Yearly Dividend Yield of 1.78%. Purely for dividend investing, there may be better candidates out there.

With a Dividend Yield of 1.78, DHCNI pays less dividend than the industry average, which is at 28.61. 89.23% of the companies listed in the same industry pay a better dividend than DHCNI!

DHCNI's Dividend Yield is slightly below the S&P500 average, which is at 2.52.

		Industry Rank	Sector Rank
Dividend Yield	1.78%

5.2 History

The dividend of DHCNI decreases each year by -45.60%.

DHCNI has been paying a dividend for over 5 years, so it has already some track record.

DHCNI has not decreased its dividend in the last 3 years.

Dividend Growth(5Y)-45.6%

Div Incr Years0

Div Non Decr Years3

5.3 Sustainability

The earnings of DHCNI are negative and hence is the payout ratio. DHCNI will probably not be able to sustain this dividend level.

DP-2.6%

EPS Next 2Y12.65%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (4/17/2025, 8:13:39 PM)

13.28

-0.38 (-2.78%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)02-25 2025-02-25/amc

Earnings (Next)05-05 2025-05-05/amc

Inst Owners75.97%

Inst Owner ChangeN/A

Ins Owners0.35%

Ins Owner ChangeN/A

Market Cap3.20B

Analysts44.44

Price Target11.31 (-14.83%)

Short Float %0%

Short Ratio0.36

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.78%

Yearly Dividend0.04

Dividend Growth(5Y)-45.6%

DP-2.6%

Div Incr Years0

Div Non Decr Years3

Ex-Date04-15 2025-04-15 (0.3515625)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)42.35%

Min EPS beat(2)-22.91%

Max EPS beat(2)107.62%

EPS beat(4)1

Avg EPS beat(4)8.41%

Min EPS beat(4)-27.3%

Max EPS beat(4)107.62%

EPS beat(8)3

Avg EPS beat(8)6.67%

EPS beat(12)3

Avg EPS beat(12)-9.02%

EPS beat(16)4

Avg EPS beat(16)-13.17%

Revenue beat(2)1

Avg Revenue beat(2)-0.56%

Min Revenue beat(2)-2.43%

Max Revenue beat(2)1.32%

Revenue beat(4)1

Avg Revenue beat(4)-0.81%

Min Revenue beat(4)-2.43%

Max Revenue beat(4)1.32%

Revenue beat(8)3

Avg Revenue beat(8)-0.59%

Revenue beat(12)4

Avg Revenue beat(12)-0.89%

Revenue beat(16)4

Avg Revenue beat(16)-1.46%

PT rev (1m)5.89%

PT rev (3m)-52.14%

EPS NQ rev (1m)12%

EPS NQ rev (3m)12%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)3.64%

Revenue NQ rev (3m)8.29%

Revenue NY rev (1m)0.26%

Revenue NY rev (3m)0.26%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.14
P/FCF	N/A
P/OCF	28.55
P/B	1.64
P/tB	1.64
EV/EBITDA	25.69

EPS(TTM)-1.05

EYN/A

EPS(NY)-0.93

Fwd EYN/A

FCF(TTM)-0.37

FCFYN/A

OCF(TTM)0.47

OCFY3.5%

SpS6.2

BVpS8.12

TBVpS8.12

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.21%
ROE	-18.9%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.31%
FCFM	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

F-Score5

Asset Turnover0.29

Health

		Industry Rank	Sector Rank
Debt/Equity	1.49
Debt/FCF	N/A
Debt/EBITDA	12.53
Cap/Depr	70.78%
Cap/Sales	13.49%
Interest Coverage	N/A
Cash Conversion	48.3%
Profit Quality	N/A
Current Ratio	2.83
Quick Ratio	2.83
Altman-Z	0.16

F-Score5

WACC7.02%

ROIC/WACCN/A

Cap/Depr(3y)103.34%

Cap/Depr(5y)92.72%

Cap/Sales(3y)19.78%

Cap/Sales(5y)17.46%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-14.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%16.28%

EPS Next Y11.5%

EPS Next 2Y12.65%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)6.04%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%5%

Revenue Next Year4.73%

Revenue Next 2Y5.48%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y28.99%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year365.69%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y60.15%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y970.52%

OCF growth 3YN/A

OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens